News | August 13, 2024
Morepen Labs Q1 FY25 profit surges 147% to Rs. 36.17 Cr
Morepen Labs successfully raised Rs. 200 Crore through QIP
Morepen Labs successfully raised Rs. 200 Crore through QIP
The pharma market is showing encouraging signs of improvement, positioning us well for future growth
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
Both departments will be equipped with specialized professionals and state-of-the-art facilities ensuring the highest standards of care
Q1 Consolidated operating profit Up 8.3%; revenue grows 7% to Rs 3,349 crore
Contepo offers a unique mechanism of action and has the potential to address increasing antibiotic resistance and gaps in the current antibiotic treatment landscape
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
DKSH’s Business Unit Consumer Goods further capitalizes on its position to strengthen the consumer health, nutrition, and baby care categories
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative
Subscribe To Our Newsletter & Stay Updated
